Thyroid Myofibroma in a Child With Turner Syndrome: Integrated Cytologic, Histopathologic, and Molecular Characterization
Pediatric and Developmental Pathology · 2026-11 · 29 (6) · 710-715
DOI: 10.1177/10935266261452369 ↗Kurz gefasst
Fallbericht in der Zeitschrift Pediatric and Developmental Pathology, online erschienen am 28.05.2026. Verfasst von Irena Manukyan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pathology and Laboratory Medicine, Children's National Hospital, Washington, DC, USA. Hauptthemen laut MEDLINE: Myofibroma, Thyroid Neoplasms, Turner Syndrome. Die Arbeit nennt 18 Literaturangaben.
Abstract (Originalsprache)
Most thyroid nodules encountered in clinical endocrinology are epithelial in origin. In contrast, primary thyroid mesenchymal tumors are exceedingly rare but increasingly recognized with advances in immunohistochemistry and molecular diagnostics. Thyroid myofibroma is an exceptionally uncommon benign fibroblastic–myofibroblastic neoplasm, with only a limited number of cases reported to date. We report a 9-year-old girl with Turner syndrome (TS) and a prior myofibroblastic proliferation of the parotid gland 5 years earlier, who presented with a solitary thyroid nodule. Fine-needle aspiration (FNA) demonstrated a spindle-cell proliferation suspicious for an extrafollicular process. Lobectomy revealed a well-circumscribed, unencapsulated spindle-cell tumor composed of bland myofibroblastic cells arranged in fascicles within a collagenous stroma. The immunophenotype supported myofibroma. Targeted molecular testing identified a pathogenic PDGFRB variant and a novel variant of uncertain significance, confirming the diagnosis. No prior reports have described thyroid myofibroma associated with TS or a preceding salivary gland myofibromatous lesion, making this case unique and diagnostically and pathogenetically significant. Awareness of this entity is critical to avoid misclassification as other spindle-cell thyroid lesions on FNA. Integrated cytomorphology, immunophenotyping, and PDGFRB-focused molecular analysis provide a robust diagnostic approach and may offer insight into shared pathogenetic mechanisms linking TS and myofibroblastic proliferations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pathology and Laboratory Medicine, Children's National Hospital, Washington, DC, USA.
- Department of Endocrinology, Children's National Medical Center, Washington, DC, USA.
- Division of Pediatric Otolaryngology, Children's National Medical Center, Washington, DC, USA.
ORCID-Profile: Irena Manukyan
Zitieren
APA
Manukyan, I., Rossi, C. T., Vaidyanathan, P., Mudd, P. A., & Sirotnikov, S. (2026). Thyroid Myofibroma in a Child With Turner Syndrome: Integrated Cytologic, Histopathologic, and Molecular Characterization. Pediatric and Developmental Pathology, 29(6), 710-715. https://doi.org/10.1177/10935266261452369
Vancouver
Manukyan I, Rossi CT, Vaidyanathan P, Mudd PA, Sirotnikov S. Thyroid Myofibroma in a Child With Turner Syndrome: Integrated Cytologic, Histopathologic, and Molecular Characterization. Pediatric and Developmental Pathology. 2026;29(6):710-715. doi:10.1177/10935266261452369
BibTeX
@article{Manukyan2026,
author = {Manukyan, Irena and Rossi, Christopher T and Vaidyanathan, Priya and Mudd, Pamela A and Sirotnikov, Sam},
title = {Thyroid Myofibroma in a Child With Turner Syndrome: Integrated Cytologic, Histopathologic, and Molecular Characterization},
journal = {Pediatric and Developmental Pathology},
year = {2026},
volume = {29},
number = {6},
pages = {710--715},
doi = {10.1177/10935266261452369}
}
EUVIMED